Biogen Inc. buy Royal Bank of Canada
Start price
19.09.24
/
50%
€180.40
Target price
19.09.25
€262.25
Performance (%)
-38.86%
Price
09:46
€110.30
Summary
This prediction is currently active. Massive losses of -38.86% have been the result for the BUY prediction by Royal_Bank_of_Canada. This prediction currently runs until 19.09.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -2.731% | -2.731% |
| iShares Core DAX® | -1.691% | 2.604% |
| iShares Nasdaq 100 | 0.913% | 3.716% |
| iShares Nikkei 225® | -2.346% | -1.208% |
| iShares S&P 500 | 0.732% | 3.130% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $292.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat